Carasent ASA (OSL: CARA)
18.90
+0.75 (4.13%)
Aug 30, 2024, 4:26 PM CET
Carasent ASA Revenue
Carasent ASA had revenue of 66.28M NOK in the quarter ending June 30, 2024, with 4.84% growth. This brings the company's revenue in the last twelve months to 254.01M, up 11.85% year-over-year. In the year 2023, Carasent ASA had annual revenue of 243.98M with 24.95% growth.
Revenue (ttm)
254.01M
Revenue Growth
+11.85%
P/S Ratio
5.47
Revenue / Employee
1.54M
Employees
165
Market Cap
1.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 243.98M | 48.72M | 24.95% |
Dec 31, 2022 | 195.26M | 58.14M | 42.40% |
Dec 31, 2021 | 137.13M | 66.55M | 94.29% |
Dec 31, 2020 | 70.58M | 22.65M | 47.26% |
Dec 31, 2019 | 47.93M | 23.96M | 99.99% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |
Navamedic ASA | 543.49M |